Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,055 | 154 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $677.49 | 21 | $0 (2021) |
| PFIZER INC. | $633.73 | 32 | $0 (2024) |
| Astellas Pharma US Inc | $293.06 | 16 | $0 (2020) |
| Ferring Pharmaceuticals Inc. | $260.92 | 16 | $0 (2024) |
| NeoTract Inc. | $247.68 | 4 | $0 (2017) |
| Veloxis Pharmaceuticals, Inc. | $165.74 | 3 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $164.57 | 5 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $140.88 | 2 | $0 (2023) |
| Vifor Pharma, Inc. | $125.00 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $120.47 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $358.13 | 16 | PFIZER INC. ($150.04) |
| 2023 | $241.44 | 11 | PFIZER INC. ($69.44) |
| 2022 | $227.12 | 7 | Veloxis Pharmaceuticals, Inc. ($117.65) |
| 2021 | $646.26 | 18 | BOSTON SCIENTIFIC CORPORATION ($153.70) |
| 2020 | $248.37 | 13 | PFIZER INC. ($81.58) |
| 2019 | $838.00 | 33 | Boston Scientific Corporation ($295.57) |
| 2018 | $463.59 | 22 | Astellas Pharma US Inc ($88.03) |
| 2017 | $1,032 | 34 | NeoTract Inc. ($247.68) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Oncology | ||||||
| 08/15/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ONCOLOGY | ||||||
| 07/02/2024 | Veloxis Pharmaceuticals, Inc. | ENVARSUS (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: TRANSPLANTATION | ||||||
| 06/27/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Oncology | ||||||
| 05/02/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: ONCOLOGY | ||||||
| 03/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $20.60 | General |
| 02/20/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: ONCOLOGY | ||||||
| 02/08/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: UROLOGY | ||||||
| 02/06/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Oncology | ||||||
| 01/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 06/28/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Urology | ||||||
| 03/07/2023 | PROCEPT BioRobotics Corporation | AQUABEAM ROBOTIC SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Urology | ||||||
| 03/02/2023 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: UROTHELIAL CANCER | ||||||
| 02/21/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: ONCOLOGY | ||||||
| 01/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: Oncology | ||||||
| 01/17/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 72 | 95 | $337,475 | $46,728 |
| 2022 | 3 | 63 | 83 | $302,302 | $37,814 |
| 2021 | 4 | 71 | 93 | $277,601 | $36,722 |
| 2020 | 4 | 79 | 120 | $275,277 | $30,033 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 28 | 29 | $323,952 | $42,749 | 13.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 22 | 44 | $8,388 | $3,120 | 37.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 22 | 22 | $5,135 | $859.71 | 16.7% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 26 | 26 | $291,200 | $34,439 | 11.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 37 | $6,904 | $2,703 | 39.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 20 | 20 | $4,198 | $672.57 | 16.0% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 22 | 22 | $244,400 | $28,735 | 11.8% |
| 50605 | Insertion of stent in urinary duct (ureter) | Facility | 2021 | 13 | 13 | $23,436 | $4,405 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 19 | 41 | $6,232 | $3,022 | 48.5% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2021 | 17 | 17 | $3,533 | $560.17 | 15.9% |
| 50360 | Transplantation of donor kidney | Facility | 2020 | 23 | 23 | $231,400 | $21,399 | 9.2% |
| 50605 | Insertion of stent in urinary duct (ureter) | Facility | 2020 | 21 | 21 | $31,889 | $4,710 | 14.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 18 | 59 | $8,968 | $3,606 | 40.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2020 | 17 | 17 | $3,021 | $317.87 | 10.5% |
About Dr. Esber Samara, MD
Dr. Esber Samara, MD is a Urology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336130756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Esber Samara, MD has received a total of $4,055 in payments from pharmaceutical and medical device companies, with $358.13 received in 2024. These payments were reported across 154 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,055).
As a Medicare-enrolled provider, Samara has provided services to 285 Medicare beneficiaries, totaling 391 services with total Medicare billing of $151,297. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Oklahoma City, OK
- Active Since 11/03/2005
- Last Updated 11/12/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1336130756
Products in Payments
- XTANDI (Drug) $620.85
- Urolift - UL400 (Device) $247.68
- FIRMAGON (Drug) $220.33
- REZUM (Device) $149.64
- MYRBETRIQ (Drug) $146.77
- GENERAL KIDNEY STONE DISEASE (Device) $136.24
- AMBICOR (Device) $125.00
- Veltassa (Drug) $125.00
- AMS 700 (Device) $124.29
- LOKELMA (Drug) $120.47
- SOLIRIS (Drug) $119.75
- Envarsus (Drug) $117.65
- (815) Thiola (Drug) $111.09
- Myrbetriq (Drug) $110.59
- THYMOGLOBULIN (Drug) $105.78
- XIAFLEX (Biological) $99.36
- Echelon Flex (Device) $99.07
- CAMCEVI (Drug) $96.08
- Cabometyx (Drug) $75.00
- Endocare Cryocare System (Device) $67.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Oklahoma City
Dr. Mohammad Ramadan, Md, MD
Urology — Payments: $158,035
Michael Cookson, Md, MD
Urology — Payments: $142,018
Basel Hassoun, Md, MD
Urology — Payments: $124,197
Dr. Kelly Stratton, Md, MD
Urology — Payments: $79,009
Dr. Ashley Bowen, M.d.,M.b.a, M.D.,M.B.A
Urology — Payments: $33,045
Sardar Mohammad Khan Galzie, Md, MD
Urology — Payments: $23,330